AMP kinase disease |
AMP-activated protein kinase |
PRKAG2 |
7q36.1 |
Cardiac hypertrophy, pre-excitation |
Autosomal dominant |
Familial amyloid disease |
Transthyretin |
TTR |
18q12.1 |
Low voltage, severe cardiac hypertrophy, paresthesias |
Autosomal dominant |
Noonan syndrome |
Protein tyrosine phosphatase, nonreceptor type 11 (aka tyrosine phosphatase SHP2) |
PTPN11 |
12q24.1 |
Short stature, facial dysmorphology, congenital heart defects, cardiac hypertrophy, skeletal anomalies, bleeding disorders, learning disabilities (variable) |
Autosomal dominant |
Son of sevenless homolog 1 |
SOS1 |
2p22.1 |
|
|
RAF proto-oncogene serine/threonine-protein kinase |
RAF1 |
3p25 |
|
|
GTPase KRas |
KRAS |
12p12.1 |
|
|
Fabry disease |
Alpha-galactosidase A |
GLA |
Xq22 |
Renal disease, paresthesias, cardiac hypertrophy |
X linked |
Females can manifest signs of disease |
Danon disease |
Lysosomal-associated membrane protein 2 |
LAMP2 |
Xq24 |
Males present in childhood with cardiac hypertrophy, skeletal myopathy, mental retardation |
X linked |
Females can manifest signs of cardiomyopathy |
Hereditary hemochromatosis |
Hereditary hemochromatosis protein |
HFE |
6p21.3 |
Iron overload, cardiomyopathy, hypogonadotropic hypogonadism, arthropathy, hepatic fibrosis or cirrhosis, diabetes mellitis, progressive skin pigmentation/bronzing |
Autosomal recessive |
Pompe disease |
Acid alpha-glucosidase (aka acid maltase) |
GAA |
17q25 |
Acid maltase deficiency (aka glycogen storage disease type II) |
Autosomal recessive |
Infantile and juvenile/adult forms |
Skeletal myopathy, ventilatory failure, cardiac hypertrophy |